Immuron (IMRN) Return on Sales (2016 - 2024)
Immuron (IMRN) posted quarterly Return on Sales of 2086148214.68% for Q4 2024, up 208614821468.0% year-on-year from N/an in Q1 2024, and up 23703124045770.85% on a QoQ basis from 0.01% in Q4 2023.
Immuron (IMRN) Return on Sales (2016 - 2024) Analysis & Trends
Immuron (IMRN) has reported Return on Sales for 9 consecutive years, with 2086148214.68% the latest figure, recorded in Q4 2024.
- Quarterly Return on Sales rose 208614821468.0% year-over-year to 2086148214.68% in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 1542799955.25% (up 154279995526.0% YoY) and the FY2025 annual result came in at 0.01%, up 1.0% from the prior year.
- Return on Sales improved to 2086148214.68% in Q4 2024 per IMRN's latest filing, from 0.01% in the prior quarter.
- Over the last five years, Return on Sales for IMRN reached as high as 2086148214.68% in Q4 2024 and fell as low as 40011.75% in Q4 2020.
- A 5-year average of 347684700.45% and a median of 0.04% in 2021 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2020 — Return on Sales plunged 4001175 bps — and 2024, when it surged 2000000000 bps.
- Year by year, Return on Sales stood at 40011.75% in 2020, then soared by 100 bps to 0.08% in 2021, then jumped by 92 bps to 0.01% in 2022, then plunged by 36 bps to 0.01% in 2023, then surged by 2000000000 bps to 2086148214.68% in 2024.
- According to Business Quant data, Return on Sales over the past three periods registered 2086148214.68%, 0.01%, and 0.15% for Q4 2024, Q4 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2,086,148,214.68% |
| Dec 31, 2023 | -0.01% |
| Jun 30, 2023 | -0.15% |
| Dec 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.08% |
| Dec 31, 2020 | -40,011.75% |
| Dec 31, 2019 | 0.00% |
| Dec 31, 2018 | -0.02% |
| Dec 31, 2017 | -0.02% |
| Dec 31, 2016 | -0.05% |
| Jun 30, 2016 | -0.04% |